skip to Global Navigation Bar skip to main content

homeHome > About Us > Recruitment > News


News Content
Daewoong Pharmaceutical’s botulinum toxin about to be released in Europe with European CHMP’s recommendation for approval
Date 2019-04-26 Hit 3037
News List
Prev Daewoong Pharmaceutical announced the excellence of Nabota through an overseas specialist training program.
Next A global symposium pays attention to Nav 1.7 Chronic Pain Treatment, DWP17061.